IPP Bureau
Merck Foundation launches $22 million initiative to improve cardiovascular care in US
By IPP Bureau - November 03, 2025
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
Jubilant Pharmova posts consolidated Q2 FY26 PAT at Rs. 120.3 Cr
By IPP Bureau - November 02, 2025
Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr
By IPP Bureau - November 02, 2025
The company has posted net profit of Rs. 283 crore for the 6 months period ended September 30, 2025
Cosmo Plastech expands rigid packaging solutions for pharma industry with PET sheets
By IPP Bureau - November 02, 2025
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
Indegene posts consolidated Q2 FY26 PAT at Rs. 102.1 Cr
By IPP Bureau - November 02, 2025
Dr Agarwals Health Care posts consolidated Q2 FY26 PAT at Rs. 29.69 Cr
By IPP Bureau - November 02, 2025
Dr Agarwals Health Care has reported total income of Rs. 506.62 crore during the period ended September 30, 2025
Dabur India reports consolidated Q2 FY26 PAT at Rs. 452.55 Cr
By IPP Bureau - November 02, 2025
Dabur India has reported total income of Rs. 3,331.45 crore during the period ended September 30, 2025
Dr. Agarwals Eye Hospital posts consolidated Q2 FY26 PAT at Rs. 19.32 Cr
By IPP Bureau - November 02, 2025
Dr Agarwals Eye Hospital has reported total income of Rs. 118.40 crore during the period ended September 30, 2025
.jpg "Cipla posts consolidated Q2 FY26 PAT Rs. 1,351.17 Cr")
Cipla posts consolidated Q2 FY26 PAT Rs. 1,351.17 Cr
By IPP Bureau - November 02, 2025
Cipla has reported total income of Rs. 7,858.39 crore during the period ended September 30, 2025
Medanta Super Speciality Hospital to set up new hospital in Guwahati
By IPP Bureau - November 02, 2025
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Tatva Chintan Pharma Chem reports consolidated Q2 FY26 PAT at Rs. 9.91 Cr
By IPP Bureau - November 02, 2025
Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025
Indraprastha Medical Corporation posts consolidated Q2 FY26 PAT at Rs. 49.46 Cr
By IPP Bureau - November 02, 2025
Indraprastha Medical Corporation has reported total income of Rs. 388.40 crore during the period ended September 30, 2025
MedPlus Health Services posts consolidated Q2 FY26 PAT at Rs. 55.50 Cr
By IPP Bureau - November 02, 2025
Medplus Health Services has reported total income of Rs. 1,696.79 crore during the period ended September 30, 2025
Zydus Wellness appoints Manish Lal as Head, Global Demand and Supply Organization
By IPP Bureau - November 02, 2025
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Bristol Myers Squibb posts Q3 2025 revenues $12.2 billion
By IPP Bureau - November 02, 2025
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
